Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON46382
NL-OMON46382
Not yet recruiting
Not Applicable

Treating the compromised hearts of patients with Rheumatoid Arthritis * Can we repair the damage? - Heart failure in RA

Overige Centra0 sites50 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Overige Centra
Enrollment
50
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Overige Centra

Eligibility Criteria

Inclusion Criteria

  • •Diagnosis of:
  • •o RA, according to the ARC/EULAR 2010 criteria (11\)
  • •\- Active disease: DAS28\*3\.2 AND C\-reactive protein \>10 mg/l OR erythrocyte sedimentation rate (ESR) \>15mm/h
  • •\- Minimal knee bending/flexion angle of 90 degrees of both knees.
  • •\- Age 40\-70 years

Exclusion Criteria

  • •\-medical history of ischemic heart disease of congestive heart failure NYHA class III/IV

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Treating the compromised hearts of patients with Rheumatoid Arthritis ¨C Can we repair the damage?
NL-OMON23785Reade50
Active, not recruiting
Phase 1
Can the heart drug enalapril prevent heart damage in patients with newly diagnosed breast cancer and lymphoma receiving chemotherapy?Prevention of cardiotoxicityMedDRA version: 20.0Level: PTClassification code 10048610Term: CardiotoxicitySystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2017-001094-16-GBSouth Tees NHS Foundation Trust170
Active, not recruiting
Phase 4
Medtronic Cardiac Ablation (Freezes the Heart Tissue to help break electrical signals) Post-Market Study platform which looks at real-world ? product safety and patient clinical outcomes.Health Condition 1: I480- Paroxysmal atrial fibrillation
CTRI/2022/02/040484India Medtronic Pvt Ltd
Recruiting
Phase 3
Treatment of cardiovascular disease with low dose Rivaroxaban in Advanced Chronic Kidney diseaseHealth Condition 1: Z992- Dependence on renal dialysis
CTRI/2020/06/025708George Institute for Global Health
Completed
Not Applicable
Does a detailed assessment for heart disease help patients who have been admitted to hospital with a flare-up of chronic obstructive pulmonary disease (COPD)?
ISRCTN26935612orthumbria Healthcare NHS Foundation Trust115